期刊
JOURNAL OF BIOLOGICAL CHEMISTRY
卷 287, 期 26, 页码 21628-21639出版社
AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M111.315168
关键词
-
资金
- National Creative Research Initiatives from Korean Ministry of Education, Science and Technology [20110018305]
- Korea Healthcare Technology Research and Development Project
- National Research Foundation of Korea (NRF) from the Ministry of Education, Science and Technology [20100019512]
- Brain Korea 21 Program fellowship award
- Seoul Science fellowship award
- NRF [2011-0016454, 2011-0019448]
- Ministry of Land, Transport and Maritime Affairs (MLTM), Korea
- Korea government (Ministry of Education, Science and Technology)
Glucose homeostasis is tightly controlled by hormonal regulation of hepatic glucose production. Dysregulation of this system is often associated with insulin resistance and diabetes, resulting in hyperglycemia in mammals. Here, we show that the orphan nuclear receptor estrogen-related receptor gamma (ERR gamma) is a novel downstream mediator of glucagon action in hepatic gluconeogenesis and demonstrate a beneficial impact of the inverse agonist GSK5182. Hepatic ERR gamma expression was increased by fasting-dependent activation of the cAMP-response element-binding protein-CRTC2 pathway. Overexpression of ERR gamma induced Pck1 and G6PC gene expression and glucose production in primary hepatocytes, whereas abolition of ERR gamma gene expression attenuated forskolin-mediated induction of gluconeogenic gene expression. Deletion and mutation analyses of the Pck1 promoter showed that ERR gamma directly regulates the Pck1 gene transcription via ERR response elements of the Pck1 promoter as confirmed by ChIP assay and in vivo imaging analysis. We also demonstrate that GSK5182, an inverse agonist of ERR gamma, specifically inhibits the transcriptional activity of ERR gamma in a PGC-1 alpha dependent manner. Finally, the ERR gamma inverse agonist ameliorated hyperglycemia through inhibition of hepatic gluconeogenesis in db/db mice. Control of hepatic glucose production by an ERR gamma-specific inverse agonist is a new potential therapeutic approach for the treatment of type 2 diabetes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据